High-throughput microbioreactor provides a capable tool for early stage bioprocess development

Abstract Tremendous advancements in cell and protein engineering methodologies and bioinformatics have led to a vast increase in bacterial production clones and recombinant protein variants to be screened and evaluated. Consequently, an urgent need exists for efficient high-throughput (HTP) screenin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mathias Fink, Monika Cserjan-Puschmann, Daniela Reinisch, Gerald Striedner
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2638648bdcb948bb8400c8e1cfce7a31
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2638648bdcb948bb8400c8e1cfce7a31
record_format dspace
spelling oai:doaj.org-article:2638648bdcb948bb8400c8e1cfce7a312021-12-02T15:23:38ZHigh-throughput microbioreactor provides a capable tool for early stage bioprocess development10.1038/s41598-021-81633-62045-2322https://doaj.org/article/2638648bdcb948bb8400c8e1cfce7a312021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81633-6https://doaj.org/toc/2045-2322Abstract Tremendous advancements in cell and protein engineering methodologies and bioinformatics have led to a vast increase in bacterial production clones and recombinant protein variants to be screened and evaluated. Consequently, an urgent need exists for efficient high-throughput (HTP) screening approaches to improve the efficiency in early process development as a basis to speed-up all subsequent steps in the course of process design and engineering. In this study, we selected the BioLector micro-bioreactor (µ-bioreactor) system as an HTP cultivation platform to screen E. coli expression clones producing representative protein candidates for biopharmaceutical applications. We evaluated the extent to which generated clones and condition screening results were transferable and comparable to results from fully controlled bioreactor systems operated in fed-batch mode at moderate or high cell densities. Direct comparison of 22 different production clones showed great transferability. We observed the same growth and expression characteristics, and identical clone rankings except one host-Fab-leader combination. This outcome demonstrates the explanatory power of HTP µ-bioreactor data and the suitability of this platform as a screening tool in upstream development of microbial systems. Fast, reliable, and transferable screening data significantly reduce experiments in fully controlled bioreactor systems and accelerate process development at lower cost.Mathias FinkMonika Cserjan-PuschmannDaniela ReinischGerald StriednerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mathias Fink
Monika Cserjan-Puschmann
Daniela Reinisch
Gerald Striedner
High-throughput microbioreactor provides a capable tool for early stage bioprocess development
description Abstract Tremendous advancements in cell and protein engineering methodologies and bioinformatics have led to a vast increase in bacterial production clones and recombinant protein variants to be screened and evaluated. Consequently, an urgent need exists for efficient high-throughput (HTP) screening approaches to improve the efficiency in early process development as a basis to speed-up all subsequent steps in the course of process design and engineering. In this study, we selected the BioLector micro-bioreactor (µ-bioreactor) system as an HTP cultivation platform to screen E. coli expression clones producing representative protein candidates for biopharmaceutical applications. We evaluated the extent to which generated clones and condition screening results were transferable and comparable to results from fully controlled bioreactor systems operated in fed-batch mode at moderate or high cell densities. Direct comparison of 22 different production clones showed great transferability. We observed the same growth and expression characteristics, and identical clone rankings except one host-Fab-leader combination. This outcome demonstrates the explanatory power of HTP µ-bioreactor data and the suitability of this platform as a screening tool in upstream development of microbial systems. Fast, reliable, and transferable screening data significantly reduce experiments in fully controlled bioreactor systems and accelerate process development at lower cost.
format article
author Mathias Fink
Monika Cserjan-Puschmann
Daniela Reinisch
Gerald Striedner
author_facet Mathias Fink
Monika Cserjan-Puschmann
Daniela Reinisch
Gerald Striedner
author_sort Mathias Fink
title High-throughput microbioreactor provides a capable tool for early stage bioprocess development
title_short High-throughput microbioreactor provides a capable tool for early stage bioprocess development
title_full High-throughput microbioreactor provides a capable tool for early stage bioprocess development
title_fullStr High-throughput microbioreactor provides a capable tool for early stage bioprocess development
title_full_unstemmed High-throughput microbioreactor provides a capable tool for early stage bioprocess development
title_sort high-throughput microbioreactor provides a capable tool for early stage bioprocess development
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/2638648bdcb948bb8400c8e1cfce7a31
work_keys_str_mv AT mathiasfink highthroughputmicrobioreactorprovidesacapabletoolforearlystagebioprocessdevelopment
AT monikacserjanpuschmann highthroughputmicrobioreactorprovidesacapabletoolforearlystagebioprocessdevelopment
AT danielareinisch highthroughputmicrobioreactorprovidesacapabletoolforearlystagebioprocessdevelopment
AT geraldstriedner highthroughputmicrobioreactorprovidesacapabletoolforearlystagebioprocessdevelopment
_version_ 1718387250742427648